+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Small Molecule Drug"

From
From
Pharmaceutical Industry Outlook, 2024 - Product Thumbnail Image

Pharmaceutical Industry Outlook, 2024

  • Report
  • April 2024
  • 86 Pages
  • Global
From
Orphan Drug Growth Opportunities - Product Thumbnail Image

Orphan Drug Growth Opportunities

  • Report
  • March 2024
  • 78 Pages
  • Global
From
Growth Indicators for Technology-enabled Drug Discovery - Product Thumbnail Image

Growth Indicators for Technology-enabled Drug Discovery

  • Report
  • June 2023
  • 77 Pages
  • Global
From
Technology Advances in Senolytics - Product Thumbnail Image

Technology Advances in Senolytics

  • Report
  • May 2023
  • 70 Pages
  • Global
From
Pharmaceuticals Outlook, 2022 - Product Thumbnail Image

Pharmaceuticals Outlook, 2022

  • Report
  • March 2022
  • 60 Pages
  • Global
From
From
AI in Pharma Global Market Opportunities and Strategies to 2032 - Product Thumbnail Image

AI in Pharma Global Market Opportunities and Strategies to 2032

  • Report
  • January 2024
  • 259 Pages
  • Global
From
Loading Indicator

The Small Molecule Drug market is a segment of the Pharmaceuticals industry that focuses on the development and production of drugs composed of small molecules. These drugs are typically used to treat a wide range of diseases, including cancer, diabetes, and cardiovascular diseases. Small molecule drugs are typically taken orally, and are designed to target specific areas of the body. The Small Molecule Drug market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of small molecule drugs, as well as the marketing and distribution of these drugs. Show Less Read more